These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 12759917)

  • 1. Conjoint analysis. The cost variable: an Achilles' heel?
    Slothuus Skjoldborg U; Gyrd-Hansen D
    Health Econ; 2003 Jun; 12(6):479-91. PubMed ID: 12759917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between reliability and size of willingness-to-pay values: a qualitative insight.
    Smith RD
    Health Econ; 2007 Feb; 16(2):211-6. PubMed ID: 16929470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient preferences for depression treatment programs and willingness to pay for treatment.
    Morey E; Thacher JA; Craighead WE
    J Ment Health Policy Econ; 2007 Jun; 10(2):73-85. PubMed ID: 17603148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between utility values and willingness to pay in patients undergoing orthognathic treatment.
    Cunningham SJ; Hunt NP
    Community Dent Health; 2000 Jun; 17(2):92-6. PubMed ID: 11349993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Willingness to pay and size of health benefit: an integrated model to test for 'sensitivity to scale'.
    Yeung RY; Smith RD; McGhee SM
    Health Econ; 2003 Sep; 12(9):791-6. PubMed ID: 12950096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valuing a hypothetical cure for rheumatoid arthritis using the contingent valuation methodology: the patient perspective.
    Fautrel B; Clarke AE; Guillemin F; Adam V; St-Pierre Y; Panaritis T; Fortin PR; Menard HA; Donaldson C; Penrod JR
    J Rheumatol; 2005 Mar; 32(3):443-53. PubMed ID: 15742435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using willingness to pay to measure family members' preferences in mental health.
    Mulvaney-Day NE
    J Ment Health Policy Econ; 2005 Jun; 8(2):71-81. PubMed ID: 15998979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Willingness-to-pay for community-based insurance in Burkina Faso.
    Dong H; Kouyate B; Cairns J; Mugisha F; Sauerborn R
    Health Econ; 2003 Oct; 12(10):849-62. PubMed ID: 14508869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of 'reference goods' in contingent valuation: should we help respondents to 'construct' their willingness to pay?
    Smith RD
    Health Econ; 2007 Dec; 16(12):1319-32. PubMed ID: 17328037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the possibility of a bridge between CBA and CEA: comments on a paper by Dolan and Edlin.
    Hansen BO; Hougaard JL; Keiding H; Østerdal LP
    J Health Econ; 2004 Sep; 23(5):887-98. PubMed ID: 15353184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eliciting several willingness to pay in a single contingent valuation survey: application to health care.
    Luchini S; Protière C; Moatti JP
    Health Econ; 2003 Jan; 12(1):51-64. PubMed ID: 12483760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Willingness to pay per quality-adjusted life year in a study of knee osteoarthritis.
    Byrne MM; O'malley K; Suarez-Almazor ME
    Med Decis Making; 2005; 25(6):655-66. PubMed ID: 16282216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do utility values and willingness to pay suitably reflect health outcome in hip and knee osteoarthritis? A comparative analysis with the WOMAC Index.
    Ethgen O; Tancredi A; Lejeune E; Kvasz A; Zegels B; Reginster JY
    J Rheumatol; 2003 Nov; 30(11):2452-9. PubMed ID: 14677192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The contingent valuation method in health care. An economic evaluation of Alzheimer's disease.
    Nocera S; Telser H; Bonato D
    Dev Health Econ Public Policy; 2003; 8():iii-xi, 1-116. PubMed ID: 15027158
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-social welfare functions: a reply to Hansen et al.
    Edlin R
    J Health Econ; 2004 Sep; 23(5):899-905. PubMed ID: 15353185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cost-utility analysis; uncertainties restrict applicability].
    de Neeling JN
    Ned Tijdschr Geneeskd; 2004 May; 148(22):1106-10. PubMed ID: 15198066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A utility-theoretic approach to the aggregation of willingness to pay measured in decomposed scenarios: development and empirical test.
    Hammerschmidt T; Zeitler HP; Leidl R
    Health Econ; 2004 Apr; 13(4):345-61. PubMed ID: 15067672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of a model analysis to estimate cost utility and value of information for intravenous immunoglobulin in Canadian adults with chronic immune thrombocytopenic purpura.
    Xie F; Blackhouse G; Assasi N; Campbell K; Levin M; Bowen J; Tarride JE; Pi D; Goeree R
    Clin Ther; 2009 May; 31(5):1082-91; discussion 1066-8. PubMed ID: 19539109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.